Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-03-31
2009-08-11
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C424S009200, C424S184100, C424S185100, C424S190100, C424S234100
Reexamination Certificate
active
07572457
ABSTRACT:
Disclosed are methods, compositions, and kits for inducing polyclonal antibodies against one or more pathogens that includeStreptococcus suis. The methods may include administering to an animal a composition that includes an isolated 38 kDa polypeptide ofStreptococcus suisand a suitable excipient. The methods, compositions, and kits may be used to immunize an animal against infection byStreptococcus suis.
REFERENCES:
patent: 5612042 (1997-03-01), Jacobs
patent: 2005/0020813 (2005-01-01), Masignani et al.
Okwumabua et al. Clincal and Diagnostic Laboratory Immunology, Apr. 2005, p. 484-490.
Li et al. Infection and Immunity, Jan. 2006, p. 305-312.
Stedman's Online medical dictionary 27th edition. Definition of neutralizing antibody.
Abbas et al. Cellular and Molecular Immunology 4th edition, 2000 Chapter 3 p. 56.
Kristensen et al. The Canadian Journal of Veterinary Research 2004; 68:66-70.
Stedman's Online medical dictionary 27th edition. Definition of neutralizing antibody, 2000.
Li, Yuanyi et al.; “Identification of a Surface Protein ofStreptococcus suisand Evaluation of Its Immunogenic and Protective Capacity in Pigs”,Infection and Immunity, vol. 74, No. 1, Jan. 2006 (pp. 305-312).
Okwumabua, Ogi et al., “Identification of the Gene Encoding a 38-Kilodalton Immunogenic and Protective Antigen ofStreptococcus suis”,Clinical and Diagnostic Laboratory Immunology, vol. 12, No. 4, Apr. 2005 (pp. 484-490).
Okwumabua, Ogi et al., “A polymerase chain reaction (PCR) assay specific forStreptococcus suisbased on the gene encoding the glutamate dehydrogenase”,FEMS Microbiology Letters, vol. 218, No. 1, Jan. 21, 2003 (pp. 79-84).
Okwumabua, Ogi et al., “Cloning and Characterization of the Gene Encoding the Glutamater Dehydrogenase ofStreptococcus suisSerotype 2”,Clinical and Diagnostic Laboratory Immunology, vol. 8, No. 2, Mar. 2001 (pp. 251-257).
Okwumabua, Ogi et al., “Hybridization Analysis of the gene encoding a hemolysin (suilysin) ofStreptococcus suistype 2: evidence for the absence of the gene in some isolates”,FEMS Microbiology Letters, vol. 181, No. 1, Dec. 1, 1999 (pp. 113-121).
Okwumabua, Ogi et al., “Detection of Genomic Heterogeneity inStreptococcus suisIsolates by DNA Restriction Fragment Length Polymorphisms of rRNA Genes (Ribotyping)”, vol. 33, No. 4,Journal of Clinical Microbiology, vol. 33, No. 4, Apr. 1995 (pp. 968-972).
Staats, J.J. et al., “Streptococcus suis: Past and Present”,Veterinary Research Communications, vol. 21, No. 6, Aug. 1997 (pp. 381-407).
Foley & Lardner LLP
Swartz Rodney P.
Wisconsin Alumni Research Foundation
LandOfFree
Use of Streptococcus suis 38 kDa polypeptide as an immunogen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of Streptococcus suis 38 kDa polypeptide as an immunogen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Streptococcus suis 38 kDa polypeptide as an immunogen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4109445